Company Filing History:
Years Active: 2013-2017
Title: Innovations by Samantha Busfield
Introduction
Samantha Busfield is an accomplished inventor based in Brunswick, Australia. She has made significant contributions to the field of medical research, particularly in the treatment of autoimmune diseases. With a total of 2 patents, her work focuses on innovative methods for targeting specific immune cells.
Latest Patents
Samantha's latest patents include groundbreaking methods for treating lupus, Sjögren's syndrome, and scleroderma. One patent details compositions and methods for targeting type 1 interferon producing cells. This method involves administering an immunoglobulin that binds to the interleukin 3 receptor alpha (IL-3Rα) chain, which depletes or partially eliminates plasmacytoid dendritic cells (pDCs) and basophils. Another patent outlines methods of treating lupus by administering humanized anti-interleukin 3 receptor alpha chain antibodies, utilizing a similar approach to target the immune response effectively.
Career Highlights
Samantha is currently employed at CSL Limited, a global biotechnology company known for its innovative therapies. Her work at CSL Limited has allowed her to collaborate with leading experts in the field and contribute to advancements in medical treatments.
Collaborations
Some of her notable coworkers include Gino Luigi Vairo and Andrew Donald Nash. Their combined expertise fosters a collaborative environment that enhances the development of new therapeutic methods.
Conclusion
Samantha Busfield's contributions to medical research through her patents demonstrate her commitment to improving treatments for autoimmune diseases. Her innovative approaches and collaborations with esteemed colleagues position her as a significant figure in the field of biotechnology.